leisure time -WSS

leisure time

author：hotspot 2025-10-02 14:39:05 - browse：65616

Kara Coluccio, a managing partner at Perspective Group poses for a portrait. -- health coverage from STAT — Kara Coluccio, a managing partner at Perspective Group, says the job market for biotech executives has gotten much tighter. Jessica Rinaldi/Globe Staff

When Crystal Shih Byers left her job at Novartis in 2020, she was excited to make the leap into a smaller startup.

Byers had spent almost nine years at Novartis, most recently helping lead a group that worked on gene therapy. But pharmaceutical companies are large and complex, and she craved more immediate impact. “I was looking for a place where I could be in the room,” she says. She wanted more autonomy, and to feel like her work would reach patients sooner.

At the time, biotech startups were rolling in cash and seeking to capture some of the magic that had fueled Moderna’s meteoric rise. They handed out lots of logo-embossed swag. “Investors were putting a lot of money into stupid science,” Byers says. “There were a lot of companies that lasted for a lot longer than I thought they would on very little data.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： With FDA staff opposed to Sarepta therapy, top official intervened

entertainment

hotspot

WSS

Bryan Kohberger seeks indictment dismissal in Idaho college killings case

Biden jokes that Republicans may impeach him because inflation is starting to cool down

Timeline: Special counsel's probe into Trump's handling of classified documents

New guidelines on severe brain injury complicate already difficult decisions

Cloning humans is technically possible. It's curious no one has tried

Why drug prescriptions should include diagnoses

Wikipedia

leisure time

knowledge

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Do masks work? RCTs can't tell us

In age of alternative facts, a scholarly course on calling out crap

As the dark side of IVF slowly comes into focus, even more transparency is needed

Cancer drug shortages should be causing more outrage

‘We were in the air.’ Mississippi family recounts surviving tornado that tore mobile home apart

Walensky prepares to leave CDC — and Congress — behind

Cloning humans is technically possible. It's curious no one has tried

Wildfire smoke exposes gaps in outdoor worker protections

Why are elite athletes different? Take a look at their microbes

knowledge

As the dark side of IVF slowly comes into focus, even more transparency is needed

'The boss' wants server deleted: New allegations emerge in Trump indictment

Gene therapy has helped boys walk. Can scientists keep it that way?

Stoke drug shows lower activity against childhood epilepsy

Interest rates are at a 22

Disclosing genetic information: not as worrisome as once feared

entertainment

focus

hotspot

explore